Skip to main content

New England Journal of Medicine Evidence – for foundation year doctors at UHNM

NEJM Evidence

This is a monthly journal publishing case studies, original research, clinical trials and reviews but it goes beyond the clinical trial, beyond the research paper. It includes exploration and analysis of the process of clinical trials and encourages critical analysis of research articles. 

Develop your skills to become more critical of the research you read and become a better evidence-based practitioner.

Unique content and features includes:

  • Tomorrow’s Trial – short articles highlighting accepted practices that lacks solid evidence and invites clinician readers to propose clinical trials to fill those gaps
  • Patient Platform - patients who have been in a clinical trial, part of a research study, or had their care impacted strongly by these, share their thoughts on their experience
  • Stats, STAT! - animated videos explaining a fundamental statistical concept

View this journal now; log in with your NHS OpenAthens username / password.

If you like that, you might like this…

  • BMJ Case Reports
  • BMJ Evidence-Based Medicine
  • Evidence-based Nursing

NHS access to full-text

NHS users need to register for an NHS OpenAthens username to access full-text for this journal – complete the online form or follow these instructions for more help.

Need more help?

Contact the Health Library for help accessing resources or finding information

Contact the eresources librarian to report a problem with any journal or for help setting up your NHS OpenAthens username

Comments

Popular posts from this blog

Clinical Key training in October 2026

 Clinical Key is a search tool providing access to wide range of content from articles, journals and ebooks to clinical overviews, patient education and drug reference texts. It is available to UHNM staff via OpenAthens login . Elsevier are offering 2 training sessions during October. Topics covered in the session include:  What is ClinicalKey? Use cases and types of content.  Benefits of registration: 24/7 access, content downloads, and personalized alerts.  Live demonstration: efficient searching, navigation, and time-saving tools.  ClinicalKey App: access from iOS and Android devices.  Additional resources: video tutorials and reference materials.  Questions and answers. Please book your session online: October 20 – 12:00 GMT  Register here for session via MS Teams October 21 – 8:00 GMT  Register here for session via Zoom For more help using Clinical Key complete our online tutorial Get Started with Clinical Key .

Login to Library Search – step-by-step instructions for NHS staff

  Library Search is a discovery tool, allowing you to find items within the library collections. You can search Library Search without logging in to view books and ebooks available in our collections. By logging in to your library account on Library Search you can access a range of additional functionality, such as: Viewing details of your library account Submitting a request to hold a book for you Adding items to your e-bookshelf Saving searches Note that for NHS users logging in to Library Search does not give you access to full-text items. As an NHS member of staff you access online resources using your NHS OpenAthens username. Anatomy of a Library Card First let’s take a quick look at the most important components of your library card. Your library card and library card number give you access to print resources as well as library services. They confirm that you are a member of the library. Your name : this will be printed on your card, so you’ll know it’s yours!...

Updates to BMJ Best Practice topics

 The following important updates have been made to BMJ Best Practice topics. NICE recommends teplizumab to delay progression to stage 3 type 1 diabetes Topic: Type 1 diabetes , Section: Management: emerging The National Institute for Health and Care Excellence (NICE) in the UK now recommends teplizumab as an option for delaying the onset of stage 3 type 1 diabetes in adults and children aged 8 years and over with stage 2 type 1 diabetes. Previously, there were no treatments available to delay progression to stage 3 disease, and management was limited to monitoring, education, and psychosocial support. European guidance lowers the bar for starting antiviral therapy in chronic HBV Topic: Hepatitis B , Section: Management: approach The European Association for the Study of the Liver (EASL) has published its updated clinical practice guideline on the management of hepatitis B virus (HBV) infection. Recommendations for when to start antiviral therapy have been updated to make sure patie...